Research fuels treatment evolution
Like most sisters, 12-year-old Carolyn and 10-year-old Miranda McConnell of Truro, Nova Scotia, have many things in common. They both have brown eyes and brown hair, and they both like swimming and playing sports.
And every day they both take medication to cope with the aching joints and fatigue they also share. Carolyn and Miranda have juvenile arthritis ( JA), a painful condition that affects one in 1,000 Canadian children under
the age of 16.
“Sometimes the pain and fatigue can slow them down, but with medication my daughters are able to live normal, active lives,” says their mother, Lea-Anne McConnell, whose third daughter, eight-year old Andrea, is symptom-free but has a 90 per cent chance of developing JA.
The rest of this article, along with more information on treatment, is available as a PDF.
The Arthritis Society: A focus on current research and treatment (4143 KB)
And every day they both take medication to cope with the aching joints and fatigue they also share. Carolyn and Miranda have juvenile arthritis ( JA), a painful condition that affects one in 1,000 Canadian children under
the age of 16.
“Sometimes the pain and fatigue can slow them down, but with medication my daughters are able to live normal, active lives,” says their mother, Lea-Anne McConnell, whose third daughter, eight-year old Andrea, is symptom-free but has a 90 per cent chance of developing JA.
The rest of this article, along with more information on treatment, is available as a PDF.
The Arthritis Society: A focus on current research and treatment (4143 KB)